Results

Total Results: 1,650 records

Showing results for "factor".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
    July 19, 2013 - index, such as vancomycin and the aminoglycosides, the risk of toxicities is often a dose-limiting factor … Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/labor-nitrous-oxide_research-protocol.pdf
    August 24, 2011 - Evidence Report on the Source: www.effectivehealthcare.ahrq.gov Published Online: August 24, 2011 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Nitrous Oxide for the Management of Labor Pain Protocol Posting Date: May 11, 2011 Amendment Date(s) if applicable: Au…
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pain-chronic_research-protocol.pdf
    July 28, 2010 - Evidence-based Practice Center Technical Brief Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: July 28, 2010 1 Evidence-based Practice Center Technical Brief Protocol Project Title: Technical Brief - Multidisciplinary Pain Programs for Chronic Non-Cancer Pain I. Background an…
  4. effectivehealthcare.ahrq.gov/sites/default/files/exposure-definition-and-measurement_chapter-4.pptx
    January 01, 2013 - In epidemiology, the term exposure can be broadly applied to any factor that may be associated with an
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol-2014.pdf
    January 01, 2014 - Symptom duration was identified as an important factor to consider; therefore an additional subquestion
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
    May 24, 2010 - Evidence Report on the Source: www.effectivehealthcare.ahrq.gov Published Online: May 24, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Effectiveness of Screening and Treatment of C. difficile Infections I. Background and Objectives for the Systematic Review Clostr…
  7. effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
    January 01, 2012 - therapies such as monoclonal antibodies (infliximab, adalimumab, tocilizumab) and tumor necrosis factor … in chronic inflammatory diseases, such as antibody production by B cells, production of rheumatic factor … with moderate to severe, active RA who had an inadequate response to at least one tumor necrosis factor
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
    January 01, 2008 - Effective Health Care Topic Number(s): 0059 Document Completion Date: 6-2-09 1 Results of Topic Selection Process & Next Steps  Bone marrow transplants (BMT) in children will go forward for refinement as a comparative effectiveness or effectiveness review. The scope of this topic, including po…
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
    January 30, 2020 - We refer to these as multivariate risk factor analyses. … Effect of methotrexate, anti-tumor necrosis factor alpha, and rituximab on the immune response to influenza
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
    September 13, 2011 - Evidence-based Practice Center Systematic Review Protocol Page 1 of 25 Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness of Hepatitis C Treatment Adherence Interventions I. Background and Objectives for the Systematic Review Hepatitis C virus (HCV) infe…
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pain-chronic_disposition-comments.pdf
    September 01, 2011 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Multidisciplinary Pain Programs for Chronic Noncancer Pain Draft review available for public com…
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/obesity-child_executive.pdf
    March 31, 2010 - 1 Comparative Effectiveness Review Number 115 Childhood Obesity Prevention Programs: Comparative Effectiveness Review and Meta-Analysis Executive Summary Background The epidemic of childhood obesity is threatening America’s children.1-3 Overweight children and adolescents are at greater risk for health pr…
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharma-treatment-pain_research-protocol-amended.pdf
    September 20, 2017 - Noninvasive, Nonpharmacological Treatment for Chronic Pain Evidence-based Practice Center Systematic Review Protocol Project Title: Noninvasive, Nonpharmacological Treatment for Chronic Pain Initial publication date if ap…
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
    January 15, 2015 - Noninvasive Testing for Coronary Artery Disease Evidence-based Practice Center Systematic Review Protocol Project Title: Noninvasive Testing for Coronary Artery D…
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
    December 16, 2011 - Pregnancy as a risk factor for restless legs syndrome. Sleep medicine. 2004;5(3):305–308. 7. … Transient RLS during pregnancy is a risk factor for the chronic idiopathic form.
  16. effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - therapies such as monoclonal antibodies (e.g., infliximab, adalimumab, tocilizumab) and tumor necrosis factor … in chronic inflammatory diseases, such as antibody production by B cells, production of rheumatic factor … with moderate to severe, active RA who had an inadequate response to at least one tumor necrosis factor
  17. S5 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
    October 01, 2007 - ORIGINAL ARTICLE Emerging Methods in Comparative Effectiveness and Safety Symposium Overview and Summary Kathleen N. Lohr, PhD Background: Interest in new methods for comparative effective- ness, drug and patient safety, and related studies is burgeoning. The advent of Medicare Part D for outpatient prescription dr…
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment-future_research.pdf
    January 01, 2014 - non-native collagen from a dressing to a recalcitrant wound may attract the excess MMPs allowing for growth factor … Currently, Becaplermin is the only FDA approved topical growth factor wound treatment available in … given Purpose: Pilot Study to Evaluate the Safety and Tolerability of Human Fibroblast Growth Factor
  19. Project Name: (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_disposition-comments.pdf
    October 25, 2011 - specific audiences. 2 Introduction I think it should clarify that age is also an important risk factor … The best study looking at OSA as a risk factor for perioperative complications is for knee and hip … It is a complicating factor, but our expert and the TEP did not think that changing definitions of OSA … Chest 2003) describing the difference between efficacy and effectiveness, a critical factor that is
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
    January 01, 2008 - Effective Health Care Topic Number(s): 0041 Document Completion Date: 6-2-09 1 Results of Topic Selection Process & Next Steps  Clostridium difficile-associated disease (CDAD) will go forward for refinement as a comparative effectiveness or effectiveness review. The scope of this topic, includi…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: